Le Lézard
Classified in: Science and technology
Subject: MAT

Raytheon completes first round of testing for new Lower Tier Air & Missile Defense radar


ANDOVER, Mass., March 17, 2020 /PRNewswire/ -- Raytheon Company [NYSE: RTN] completed the first round of testing of the first partially populated radar antenna array for the U.S. Army's Lower Tier Air and Missile Defense Sensor, or LTAMDS. The milestone comes less than five months after the U.S. Army selected Raytheon to build LTAMDS, a next-generation radar that will defeat advanced threats like hypersonic weapons.

"Concluding these initial tests brings Raytheon one step closer to putting LTAMDS into the hands of service members," said Tom Laliberty, vice president of Integrated Air and Missile Defense at Raytheon's Integrated Defense Systems business. "Raytheon and our supplier partners continue to make the right investments in people, technology and manufacturing capability to ensure we meet the U.S. Army's Urgent Materiel Release."

The testing consisted of calibrating LTAMDS primary antenna array in an indoor, climate controlled test range, and evaluating its performance against simulated targets. With testing complete, the array is being mounted on a precision-machined enclosure for integration and further evaluation. It will then commence testing at an outdoor range against real-world targets.

LTAMDS consists of a primary antenna array on the front of the radar, and two secondary arrays on the rear. The radar antennas work together to enable operators to simultaneously detect and engage multiple threats from any direction, ensuring there are no blind spots on the battlefield. LTAMDS' primary array is roughly the same size as the Patriottm radar array, but provides more than twice Patriot's performance. While it is designed for the U.S. Army's Integrated Air and Missile Defense system, LTAMDS will also be able to preserve previous Patriot investments.

Raytheon is working closely with hundreds of suppliers across 42 states, including a core team playing a strategic role in building the LTAMDS solution. They are:

About Raytheon

Raytheon Company, with 2019 sales of $29 billion and 70,000 employees, is a technology and innovation leader specializing in defense, civil government and cybersecurity solutions. With a history of innovation spanning 98 years, Raytheon provides state-of-the-art electronics, mission systems integration, C5I® products and services, sensing, effects, and mission support for customers in more than 80 countries. Raytheon is headquartered in Waltham, Massachusetts. Follow us on Twitter.

Media Contact
Mike Nachshen
+ 1.520.269.5697
[email protected]

SOURCE Raytheon Company


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: